We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-5.3%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$791M
AUM Growth
-$139M
(-15%)
Cap. Flow
-$89.2M
Cap. Flow
% of AUM
-11.28%
Top 10 Holdings %
Top 10 Hldgs %
26.18%
Holding
586
New
64
Increased
133
Reduced
194
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$19.9M |
| 2 |
GameStop
GME
|
+$19.5M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$19.1M |
| 4 |
Eastman Chemical
EMN
|
+$19M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$25.8M |
| 2 |
Vulcan Materials
VMC
|
+$24.1M |
| 3 |
CVS Health
CVS
|
+$23.6M |
| 4 |
Tyson Foods
TSN
|
+$23.6M |
| 5 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.4% |
| 2 | Industrials | 14.28% |
| 3 | Consumer Staples | 5.75% |
| 4 | Technology | 5.6% |
| 5 | Materials | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$293M
| $736K | 0.09% |
16,969
+529
| +3% | +$24.2K |
|
|
LNKD
102
DELISTED
LinkedIn Corporation
LNKD
| $721K | 0.09% |
3,793
-597
| -14% | -$119K |
|
103
Freeport-McMoran
FCX
$90B
| $694K | 0.09% |
71,614
+1,094
| +2% | +$13.1K |
|
104
iShares MSCI Malaysia ETF
EWM
$305M
| $687K | 0.09% |
17,332
+7,108
| +70% | +$310K |
|
105
Oceaneering
OII
$5.25B
| $668K | 0.08% |
17,013
-3,899
| -19% | -$162K |
|
106
CALL
Southern Company
SO
$110B
| $662K | 0.08% |
2,550
| – | – |
|
107
Boeing
BA
$165B
| $658K | 0.08% |
5,023
-299
| -6% | -$41.5K |
|
|
X
108
DELISTED
US Steel
X
| $639K | 0.08% |
61,364
+29,295
| +91% | +$490K |
|
109
General Motors
GM
$74.7B
| $639K | 0.08% |
21,280
-9,397
| -31% | -$288K |
|
110
ArcelorMittal
MT
$50.4B
| $609K | 0.08% |
51,744
+6,555
| +15% | +$122K |
|
111
Bank of America
BAC
$435B
| $604K | 0.08% |
38,761
+25,018
| +182% | +$421K |
|
112
Sysco
SYY
$39.7B
| $591K | 0.07% |
15,162
-2,202
| -13% | -$84K |
|
|
LTM
113
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $585K | 0.07% |
119,894
+14,499
| +14% | +$84.2K |
|
114
Banco Santander Chile
BSAC
$15.8B
| $584K | 0.07% |
32,052
+31,877
| +18,215% | +$623K |
|
115
Pfizer
PFE
$140B
| $583K | 0.07% |
19,559
+4,258
| +28% | +$137K |
|
116
iShares MSCI Japan ETF
EWJ
$21.7B
| $566K | 0.07% |
12,389
+11,900
| +2,434% | +$587K |
|
117
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $555K | 0.07% |
5,221
+1,400
| +37% | +$152K |
|
118
Telecom Argentina
TEO
$5.89B
| $555K | 0.07% |
38,139
-27,389
| -42% | -$449K |
|
119
NRG Energy
NRG
$29.8B
| $554K | 0.07% |
37,290
+1,456
| +4% | +$28.9K |
|
120
Qualcomm
QCOM
$176B
| $543K | 0.07% |
10,109
-1,185
| -10% | -$70.4K |
|
121
PG&E
PCG
$47.8B
| $534K | 0.07% |
10,112
-1,053
| -9% | -$53.8K |
|
122
Merck
MRK
$324B
| $515K | 0.07% |
+10,933
| New | +$581K |
|
123
CME Group
CME
$92.2B
| $507K | 0.06% |
5,471
-565
| -9% | -$53.7K |
|
124
Cemex
CX
$17.4B
| $501K | 0.06% |
77,554
-27,612
| -26% | -$205K |
|
125
Banco Bradesco
BBD
$38.1B
| $473K | 0.06% |
187,627
+109,123
| +139% | +$368K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2015 Portfolio in Review
As of Q3 2015, Exane Derivatives held 586 positions worth $791M, down 15% from $930M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Exane Derivatives withdrew a net $89.2M in Q3 2015, closing 58 positions and reducing 194 holdings. Its most notable exit was HCA Healthcare, an estimated $25.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 13% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Exane Derivatives opened a new position in McKesson worth $17.4M.
- Exane Derivatives's largest Q3 2015 buy was McKesson: 94,079 shares worth $17.4M.
- Exane Derivatives added most to Eastman Chemical in Q3 2015, an estimated $19M increase.
- Exane Derivatives's biggest Q3 2015 reduction was Vulcan Materials, cutting an estimated $24.1M.
- Exane Derivatives fully exited HCA Healthcare in Q3 2015, selling an estimated $25.8M.
- Exane Derivatives's ten largest holdings make up 26% of its $791M portfolio in Q3 2015.
- Exane Derivatives opened 64 new positions and closed 58 in Q3 2015.
- Exane Derivatives's portfolio value fell 15% quarter-over-quarter to $791M.
Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.